Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

7.45
Delayed Data
As of Sep 20
 -0.08 / -1.06%
Today’s Change
6.07
Today|||52-Week Range
25.00
-51.69%
Year-to-Date

Today’s Trading

Previous close7.53
Today’s open7.57
Day’s range7.38 - 7.70
Volume17,955,302
Average volume (3 months)21,076,024
Market cap$8.1B
Data as of 6:30pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+85.71%
Earnings growth (this year)-18.82%
Earnings growth (next 5 years)+2.20%
Revenue growth (last year)-16.69%
P/E ratioNM
Price/Sales0.84
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
BGNEBeigene Ltd+2.57+1.93%
BBIOBridgeBio Pharma Inc+1.74+7.09%
AKRXAkorn Inc+0.43+11.72%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 1, 2019
EPS forecast (this quarter)$0.58
Annual revenue (last year)$18.8B
Annual profit (last year)-$2.1B
Net profit margin-11.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts